Steinberg Global Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,000
Closed -$309K 235
2018
Q1
$309K Sell
4,000
-1,210
-23% -$97.4K 0.05% 207
2017
Q4
$440K Sell
5,210
-18
-0.3% -$1.53K 0.06% 187
2017
Q3
$447K Sell
5,228
-106
-2% -$8.69K 0.07% 181
2017
Q2
$439K Buy
5,334
+104
+2% +$8.48K 0.07% 181
2017
Q1
$440K Buy
+5,230
New +$419K 0.07% 174
2016
Q4
Sell
-2,960
Closed -$238K 233
2016
Q3
$238K Buy
+2,960
New +$237K 0.04% 199
2016
Q1
Sell
-3,690
Closed -$311K 221
2015
Q4
$311K Hold
3,690
0.06% 179
2015
Q3
$309K Sell
3,690
-1,881
-34% -$159K 0.06% 171
2015
Q2
$465K Sell
5,571
-64,875
-92% -$4.94M 0.09% 153
2015
Q1
$5.12M Sell
70,446
-6,609
-9% -$471K 1.03% 34
2014
Q4
$5.32M Buy
77,055
+4,139
+6% +$279K 1.15% 30
2014
Q3
$4.73M Buy
72,916
+3,490
+5% +$221K 1.08% 36
2014
Q2
$4.32M Buy
69,426
+2,582
+4% +$154K 1% 35
2014
Q1
$3.93M Buy
66,844
+2,200
+3% +$123K 0.98% 34
2013
Q4
$3.3M Buy
64,644
+8,850
+16% +$443K 0.7% 50
2013
Q3
$2.81M Buy
55,794
+245
+0.4% +$12.8K 0.62% 50
2013
Q2
$2.73M Buy
+55,549
New +$3.02M 0.71% 44

Other funds holding LLY

Steinberg Global Asset Management's LLY Position: Q2 2018 in Review

Steinberg Global Asset Management sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 4,000 shares — an estimated $309K sold.

Steinberg Global Asset Management first reported a position in LLY in Q2 2013 and held it in 17 quarters. The position peaked at $5.32M in Q4 2014. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Steinberg Global Asset Management reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Steinberg Global Asset Management sold 4,000 Eli Lilly shares in Q2 2018, an estimated $309K.
  • Steinberg Global Asset Management first reported a position in Eli Lilly in Q2 2013 and held it in 17 quarters.
  • Steinberg Global Asset Management's Eli Lilly position peaked at $5.32M in Q4 2014.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Steinberg Global Asset Management's 13F filing for Q2 2018, filed 3 Aug 2018.